GSK PLC - Daprodustat approved by US FDA for anaemia of CKD

RNS Number: 6652 O GSK PLC 02 February 2023 Issued: 2 February 2023, London UK. Jesduvroq approved by US FDA for anaemia of chronic kidney disease in adults on dialysis. ·Jesduvroq is the only oral HIF-PHI approved in the US, offering adults on dialysis with anaemia of chronic kidney disease a new oral treatment option.